EDITORIAL
Role of Toxicologic Pathology in Advancing Understanding of Previously Identified Hazards, Current Safety Assessments, and Mechanism of Action for Therapeutic Xenobiotics Toxicologic pathologists have a central role in the process of identifying hazards and providing proper interpretation of these hazards for appropriate safety assessments. Additionally, toxicologic pathologists guide the discovery of new chemical entities with an understanding of disease processes and interpretation of morphological alterations that may help determine how a drug can affect a biological system. To facilitate this process, Toxicologic Pathology has established a section in the journal devoted to Investigative Toxicologic Pathology. This section will contain submitted papers, invited reviews, and editorials which focus on: (a) emerging strategies for evaluating and identifying hazards and characterizing risk, (b) in vivo, in vitro, and molecular biological studies that provide a mechanistic basis for interpreting and predicting morphological alterations, and (c) new methods that improve the process of hazard identification.
In this issue of Toxicologic Pathology, 3 papers have been selected to illustrate how this section can be a forum to advance our understanding of identified hazards, improve current safety assessments, and illustrate the mechanism by which xenobiotics can improve health.
The role of Toxicologic Pathology in advancing the understanding of identified hazards is demonstrated by Blazka et al at the National Institute of Environmental Health Sciences. Using a toxicologic pathology approach, this group expands the mechanistic basis for acetaminophen-induced liver toxicity (3) . These studies demonstrate that increased production of two cytokines, TNFa. and/or IL-la, modulates acetaminophen-induced liver injury. These findings also provide a basis for the observation that activated Kupffer cells are involved with the pathophysiologic response to acetaminophen-induced hepatic toxicity.
Defining the factors involved in the induction of rodent lesions provides critical information for assigning potential levels of risk for humans exposed to acetaminophen.
As this relates to the response observed in humans, such information establishes potential biomarkers to track responses that are observed clinically, thereby reducing the potential of untoward effects of acetaminophen. By using several tools available to the toxicologic pathologist, Blazka et al unify previously identified studies by the Luster (4) and Laskin (8, 9, 10) laboratories to demonstrate that the development and resolution of acetaminophen-induced liver toxicity is partially mediated by cytokines released from Kupffer cells. This article and related publications demonstrate the role of the toxicologic pathologist, not only in hazard identification, but also in providing a mechanistic basis for already-identified hazards.
The role of Toxicologic Pathology in advancing our understanding of ongoing safety assessments is illustrated in the article presented by Albores' laboratory. This group demonstrates that phenobarbital induction of liver cytochrome P-450 activity can exacerbate the acute hepatotoxicity of arsenite (2) . Since humans are naturally exposed to a wide range of organic and inorganic xenobiotics in the environment, some of which increase cytochrome P-450 activity, it is important to understand how alterations in hepatocellular metabolic activity might influence the toxicity profiles of various chemicals. Several papers have shown that altered metabolism can change the liver response to organic xenobiotics (6); however, the demonstration that a liver with activated cytochrome P-450 enzymes is more susceptible to elemental toxicity is challenging. Although Albores' group did not provide a mechanistic basis for their observations, an increased energy demand by the metabolically accelerated hepatocyte coupled with arsenite's role in inhibiting ATP synthesis (5, 7) seems reasonable (2) . An additional site of potential interaction between phenobarbital and arsenite is the hemooxygenase enzyme that is induced by arsenite (1) . Hemooxygenase has been shown to be ratelimiting in the oxidative catabolism of heme to bile pigments (12) . Investigation into metabolism and bilirubin excretion under conditions employed in the current studies may provide additional insights into the interaction of arsenite and induced cytochrome P-450. By combining metabolism and toxicologic pathology approaches, inves-tigations such as those conducted by Albores and others provide understanding of current safety assessments and insight into making extrapolations from laboratory animals to free-living humans.
The role of Toxicologic Pathology in presenting a basis for the mechanism of action for therapeutic xenobiotics is illustrated by Stark et al (11) . This group used computer-aided image analysis to enhance the mechanistic understanding of how fiber modifies the intestinal mucosa and plays a role in the hypocholesterolemic effects of dietary fibers (11) . These studies demonstrate that the intestines of rats fed soluble fiber had greater mucosal thickness and intestinal length than did nonfermentable fiber or control-diet-fed animals. Stark et al speculate that these structural modifications may lead to changes in the absorptive capacity of the intestines. How these modifications relate to altered cholesterol levels and the impaired lipid absorption following pectin feeding remains to be demonstrated. Observations by this group and others illustrate the utility of modem approaches of toxicologic pathology, which include molecular biology tools and image analysis, in evaluating morphologic alterations and helping to define the mechanism whereby a xenobiotic has therapeutic benefit.
The collection of articles in the Investigative Toxicologic Pathology Section of this issue of Toxicologic Pathology illustrates how toxicologic pathologists can bring a pivotal viewpoint when interpreting tissue alterations induced by various environmental and therapeutic agents. Findings such as these will provide fundamental understandings that can be used to form the foundation of improved safety assessments or the development of new and more efficacious xenobiotics. These papers also illustrate the global &dquo;team&dquo; of toxicologic pathologists that are contributing to the advancement of our understanding of xenobiotic-induced changes. In the future, the Investigative Toxicologic Pathology Section of Toxicologic Pathology will focus on studies that take a hypothesis-testing approach, using modem tools of the toxicologic pathologist to provide mechanistic understanding of xeno-biotic-induced alterations in organs, tissues, cells, and subcellular organelles. T. A. Bertram, D.V.M., Ph.D.
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